Clinical Trial Update: A Clinical Study of 9MW2821 in Subjects With Advanced Malignant Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for 9MW2821 in advanced malignant solid tumors across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• 9MW2821

Snippet

Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd. | Conditions: Solid Tumors | Phase 1, Phase 2 | Status: UNKNOWN